CN1698735A - Medicine for treating psoriasis - Google Patents
Medicine for treating psoriasis Download PDFInfo
- Publication number
- CN1698735A CN1698735A CN 200510043272 CN200510043272A CN1698735A CN 1698735 A CN1698735 A CN 1698735A CN 200510043272 CN200510043272 CN 200510043272 CN 200510043272 A CN200510043272 A CN 200510043272A CN 1698735 A CN1698735 A CN 1698735A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- raw material
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention discloses a medicine for treating psoriasis which comprises the following raw materials (by weight portion), astragalus root 30-80, white atractylodes rhizome 6-15, ledebouriella root 6-15, root of pilose asiabell 12-30, peach kernel 9-20, safflower 10-18, Ligusticum wallichii 6-15, Chinese dittany bark 10-19, Chinese angelica root 6-20, puncturevine 6-15, scrophulariaceae 12-20.
Description
Technical field
The present invention relates to Chinese medicine, is the psoriatic medicine of a kind of treatment.
Background technology
Psoriasis is the dermatosis that a kind of frequent recurrence is healed than refractory, is commonly called as chronic eczema, tinea corporis, psoriasis, psoriasis etc.Treating psoriatic medicine major part is medicine for external use, as: Yin Like, the silver-colored king of gram etc., being applied to the affected part has certain effect, but therapeutic effect is relatively poor, does not have cure rate.Oral medicine commonly used has aminopterin, day deer Xiaoyin capsule, enlightening silver strip, hormone etc., and the effect of this class medicine is of short duration, and some side effect is arranged, and particularly the amcinonide in the medicine components is bigger to the injury of human body.The Chinese medicine preparation of disclosed treatment silver bits characteristics are respectively arranged, but wherein many preparation effects is not good enough.
Summary of the invention
The purpose of this invention is to provide the psoriatic medicine of a kind of treatment, it is a pure Chinese medicinal preparation, does not contain hormone, and therapeutic effect is remarkable, and human body is had no side effect.
The present invention is achieved through the following technical solutions for achieving the above object: the psoriatic medicine of a kind of treatment, and it comprises the raw material of following weight parts: Radix Astragali 30-80, Rhizoma Atractylodis Macrocephalae 6-15, Radix Saposhnikoviae 6-15, Radix Codonopsis 12-30, Semen Persicae 9-20, Flos Carthami 10-18, Rhizoma Chuanxiong 6-15, Cortex Dictamni 10-19, Radix Angelicae Sinensis 6-20, living Fructus Tribuli 6-15, Radix Scrophulariae 12-20.The psoriatic medicine of described a kind of treatment, the raw material of weight portion is: Radix Astragali 30-60, Rhizoma Atractylodis Macrocephalae 8-12, Radix Saposhnikoviae 8-12, Radix Codonopsis 17-23, Semen Persicae 13-17, Flos Carthami 13-17, Rhizoma Chuanxiong 7-11, Cortex Dictamni 13-18, Radix Angelicae Sinensis 13-17, living Fructus Tribuli 7-11, Radix Scrophulariae 15-17.The psoriatic medicine of described a kind of treatment also has the raw material of following weight portion: Radix Rehmanniae 6-15, Flos Sophorae 9-15, Flos Lonicerae 6-12, Radix Arnebiae (Radix Lithospermi) 6-12 in this component.The psoriatic medicine of described a kind of treatment also has the raw material of following weight portion: Radix Rehmanniae 6-15, Radix Rehmanniae Preparata 6-12, Fructus Cannabis 3-12 in this component.The psoriatic medicine of described a kind of treatment also has the raw material of following weight portion in this component: Radix Salviae Miltiorrhizae 9-15, the system breast does not have 3-12, rhizoma sparganic 6-15, Rhizoma Curcumae 6-15.
The Radix Astragali in the medicine components of the present invention is to reuse component, commands the through sick institute of all medicines with reinforcing body resistance, and its effect is: tonifying Qi and lifting yang, benefiting QI for strengthening the superficies, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent.The Rhizoma Atractylodis Macrocephalae has air making-up and spleen enlivening, help the Radix Astragali to strengthen the merit of benefiting QI for strengthening the superficies, make that the prosperous table of gas is real, heresy is not objective in table, dampness diuretic, the effect that removes flesh heat, Radix Saposhnikoviae then has the effect of the spasmolytic of dispeling the wind, dehumidify, relieve the pain, for receiving better therapeutic, be aided with Radix Codonopsis invigorating the spleen and replenishing QI relieving restlessness, the detoxifcation of Radix Scrophulariae removing heat from blood YIN nourishing, Cortex Dictamni, living Fructus Tribuli dispelling wind for relieving itching, heat-clearing and toxic substances removing, broken dry, the Rhizoma Chuanxiong circulation of qi promoting wind-expelling pain-stopping of blood-retention dehematize of Semen Persicae, nourshing blood and promoting blood circulation, all medicines share, benefiting QI for strengthening the superficies nourishes blood, invigorates blood circulation, dispels the wind, and it is flourish that the skin space between skin and muscles is got.
Medicine of the present invention for the heat in blood patient, also can increase the Radix Rehmanniae, Flos Sophorae, Flos Lonicerae and Radix Arnebiae (Radix Lithospermi) for reaching better effect, to reach further heat reliving and toxin-eliminating, clearing away heat and cooling blood, Yin-nourishing and body fluid promoting, the clear effect of doing sluicing, removing heat from blood and promoting blood circulation.For the dry patient of blood, also can increase the Radix Rehmanniae, Radix Rehmanniae Preparata, Fructus Cannabis, to reach effects such as further heat clearing away, removing heat from blood, the YIN nourishing of enriching blood, Yin-nourishing and body fluid promoting.For the blood stasis patient, also can increase Radix Salviae Miltiorrhizae, system breast and do not have, rhizoma sparganic and Rhizoma Curcumae, to reach pain, nourishing blood to tranquillize the mind, removing blood stasis pain relieving, the circulation of qi promoting effects such as disease that disappear that disappear of further removing heat from blood.
Medicine of the present invention rises by treatment back cAMP, and cGMP descends, and cAMP/cGMP ratio increases, and shows that the benefiting QI for strengthening the superficies treatment can adjust cyclic nucleotide content, makes it recover normal, thereby suppresses the cell of hyper-proliferative, promotes cell differentiation and brings into play therapeutical effect.The domestic cAMP of deficiency of vital energy yang deficiency patient that studies confirm that in recent years descends, and CGMP increases, and CAMP/CGMP ratio descends, immunologic function disorder, and the tissue blood amount reduces.
Take from the medicine of the present invention, the adult eats 20 pieces of sun-dried Fructus Jujubaes morning on an empty stomach, with vitimin supplement, aminoacid etc., auxiliary treatment effect is preferably arranged, and simultaneously, avoids ichthyophagy, shrimp, Fructus Capsici, rareripe, living Bulbus Allii.
When the present invention prepares, each component is taken by weighing by weight, put into water and soak, decoct the filtering residue extracting juice then.Potion divided and took for three times every day.To the patient who cures, adopt to be interrupted and consolidates drug regimen, in back 1 month of healing, obey two doses of medicines of the present invention weekly, to cure in 2-3 month, the potion of taking medicine weekly the shortlyest is no less than 2 months.
Clinical 500 examples of the present invention, inpatient's 260 examples, outpatient's 240 examples; Man's 280 examples, women 220 examples are wherein accepted treatments such as ethyliminum, hormone, Chinese medicine, the time heavy author's 382 examples of sending out repeatedly when light, the first treatment of 118 examples.Age 9-55 year, carry out phases 180 example, resting stages 300 example, paracmasises 20 example; The course of disease 20 days-30 years, wherein 5 years with interior 330 examples, 170 examples more than 5 years.Among the 500 routine patients, wherein 481 example recoveries from illness (erythra disappears fully or disappears more than 95%), 9 examples fail to adhere to that because of financial difficulties Drug therapy does not heal.In 481 routine cured persons, wherein a course of therapy 58 examples are cured 325 examples two courses of treatment, cure 112 examples three courses of treatment, four courses of treatment, above 3 examples of curing were followed up a case by regular visits to 481 examples of curing, recurrence 3 examples in the 1-1.5, all than mild symptoms before the treatment, erythra is few for recurrence back patient, and it is still effective to take medicine again.
Model case
1, Zhao * *, man 50 years old workman, admission number: 00176
Be in hospital the date: on January 12nd, 2003
Suffer from the psoriasis more than two decades, once used multiple Drug therapys such as ethyliminum, aminopterin, hormone and Chinese medicine invalid.The general rubescent speckle shape red rash of women's head-ornaments portion, extremity and trunk, the surface is floating to be had than thin white squama, is easy to peel off, and basilar part is scarlet, and sieve shape petechia is arranged, and new rash constantly occurs, and pruritus is obvious.In recent years, the patient often caught a cold, companion's limbs fatigue, and xerostomia is urinated red, red tongue, yellow and thin fur, slippery and rapid pulse.Card belongs to deficiency of vital energy wind and contains heat in blood, controls suitable benefiting QI for strengthening the superficies, removing pathogenic heat from blood and toxic substance from the body.After obeying 20 doses of medicines of the present invention, erythra disappears more than half, and pruritus is alleviated substantially, the surplus erythra speckle complexion changed purple of institute is dim, increases do not continue 25 doses of clothes of rhizoma sparganic, Rhizoma Curcumae, Radix Salviae Miltiorrhizae, system breast again, and it is normal that skin recovers, former erythra place leaves over the vestige of pigmentation, follows up a case by regular visits to two and half not recurrences again.
2, Lee * *, man 40 years old teacher, December in 2003 first visit on the 8th.
It is surplus to suffer from psoriasis 12 years, and once at hospital's multi-treatments such as this area and other places, poor effect still is regardless of the outbreak in season, does not prolongedly move back.Existing erythra dispersed whole body is the speckle shape, and base coat colour is dim red, and surperficial silver gray has thicker dry squama, clear border, and the sieve shape is hemorrhage not obvious at the bottom of the erythra stripping group, and heavy when light during pruritus, companion Mian Se Koushi is white, is hard and dry pale tongue with thin fur, soft and thready pulse.Card belongs to deficiency of vital energy blood-deficiency and wind-dry, controls suitable benefiting QI for strengthening the superficies, blood enriching and dryness moistening.After taking one week of pharmaceutical preparation of the present invention, erythra obviously disappears, and gargalesthesia also obviously alleviates, and does not see the new erythra that rises, and free movement of the bowels connects 15 doses of clothes, and it is normal that skin recovers, and follows up a case by regular visits to so far not recurrence.
The specific embodiment
Embodiment
1, the Radix Astragali 30, the Rhizoma Atractylodis Macrocephalae 6, Radix Saposhnikoviae 6, Radix Codonopsis 12, Semen Persicae 9, Flos Carthami 10, Rhizoma Chuanxiong 6, Cortex Dictamni 10, Radix Angelicae Sinensis 6, Radix Scrophulariae 12, living Fructus Tribuli 6.
2, the Radix Astragali 80, the Rhizoma Atractylodis Macrocephalae 15, Radix Saposhnikoviae 15, Radix Codonopsis 30, Semen Persicae 20, Flos Carthami 18, Rhizoma Chuanxiong 15, Cortex Dictamni 19, Radix Angelicae Sinensis 20, Radix Scrophulariae 20, living Fructus Tribuli 15.
3, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9.
4, the Radix Astragali 30, the Rhizoma Atractylodis Macrocephalae 8, Radix Saposhnikoviae 8, Radix Codonopsis 17, Semen Persicae 13, Flos Carthami 13, Rhizoma Chuanxiong 7, Cortex Dictamni 13, Radix Angelicae Sinensis 13, Radix Scrophulariae 15, living Fructus Tribuli 7.
5, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 12, Radix Saposhnikoviae 12, Radix Codonopsis 23, Semen Persicae 17, Flos Carthami 17, Rhizoma Chuanxiong 11, Cortex Dictamni 18, Radix Angelicae Sinensis 17, Radix Scrophulariae 17, living Fructus Tribuli 11.
6, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Flos Sophorae 9, Flos Lonicerae 6, Radix Arnebiae (Radix Lithospermi) 6.
7, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Flos Sophorae 15, Flos Lonicerae 12, Radix Arnebiae (Radix Lithospermi) 12.
8, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Radix Rehmanniae Preparata 6, the Radix Rehmanniae 6, Fructus Cannabis 3.
9, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Radix Rehmanniae Preparata 12, the Radix Rehmanniae 15, Fructus Cannabis 12.
10, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Radix Salviae Miltiorrhizae 9, system breast do not have 3, rhizoma sparganic 6, Rhizoma Curcumae 6.
11, the Radix Astragali 60, the Rhizoma Atractylodis Macrocephalae 10, Radix Saposhnikoviae 10, Radix Codonopsis 20, Semen Persicae 15, Flos Carthami 15, Rhizoma Chuanxiong 9, Cortex Dictamni 15, Radix Angelicae Sinensis 15, Radix Scrophulariae 15, living Fructus Tribuli 9, Radix Salviae Miltiorrhizae 15, system breast do not have 12, rhizoma sparganic 15, Rhizoma Curcumae 15.
The raw material of above-mentioned each component all adopts the decocting method of Chinese medicine to produce drug oral, also can adopt known method to make adhesive tape or tablet.The present invention is not limited among the foregoing description.
Claims (5)
1, the psoriatic medicine of a kind of treatment, it is characterized in that: it comprises the raw material of following weight parts: Radix Astragali 30-80, Rhizoma Atractylodis Macrocephalae 6-15, Radix Saposhnikoviae 6-15, Radix Codonopsis 12-30, Semen Persicae 9-20, Flos Carthami 10-18, Rhizoma Chuanxiong 6-15, Cortex Dictamni 10-19, Radix Angelicae Sinensis 6-20, living Fructus Tribuli 6-15, Radix Scrophulariae 12-20.
2, the psoriatic medicine of a kind of treatment according to claim 1, it is characterized in that: the raw material of weight portion is: Radix Astragali 30-60, Rhizoma Atractylodis Macrocephalae 8-12, Radix Saposhnikoviae 8-12, Radix Codonopsis 17-23, Semen Persicae 13-17, Flos Carthami 13-17, Rhizoma Chuanxiong 7-11, Cortex Dictamni 13-18, Radix Angelicae Sinensis 13-17, living Fructus Tribuli 7-11, Radix Scrophulariae 15-17.
3, the psoriatic medicine of a kind of treatment according to claim 1 and 2 is characterized in that: the raw material that also has following weight portion in this component: Radix Rehmanniae 6-15, Flos Sophorae 9-15, Flos Lonicerae 6-12, Radix Arnebiae (Radix Lithospermi) 6-1 2.
4, the psoriatic medicine of a kind of treatment according to claim 1 and 2 is characterized in that: the raw material that also has following weight portion in this component: Radix Rehmanniae 6-15, Radix Rehmanniae Preparata 6-12, Fructus Cannabis 3-12.
5, the psoriatic medicine of a kind of treatment according to claim 1 and 2 is characterized in that: the raw material that also has following weight portion in this component: Radix Salviae Miltiorrhizae 9-15, the system breast does not have 3-12, rhizoma sparganic 6-15, Rhizoma Curcumae 6-15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100432720A CN1332702C (en) | 2005-04-25 | 2005-04-25 | Medicine for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100432720A CN1332702C (en) | 2005-04-25 | 2005-04-25 | Medicine for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1698735A true CN1698735A (en) | 2005-11-23 |
| CN1332702C CN1332702C (en) | 2007-08-22 |
Family
ID=35475087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100432720A Expired - Fee Related CN1332702C (en) | 2005-04-25 | 2005-04-25 | Medicine for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1332702C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101628057B (en) * | 2009-08-14 | 2011-04-13 | 南宁市维威制药有限公司 | Pharmaceutical composition for treating senile skin pruritus and preparation method thereof |
| CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
| CN105770817A (en) * | 2016-04-08 | 2016-07-20 | 陈正琴 | Qi-tonifying, blood-activating, dehumidifying and detoxifying different-skin-disease-treating traditional-Chinese-medicine composition formula |
| CN106038859A (en) * | 2016-06-29 | 2016-10-26 | 合江商业街阳春中医诊所 | Traditional Chinese medicine composition and preparation method thereof |
| CN106491772A (en) * | 2016-02-03 | 2017-03-15 | 中卫清华园生物科技有限公司 | One kind treats psoriasic external use health medicine |
| CN110123983A (en) * | 2018-02-02 | 2019-08-16 | 郑思维 | Chinese medicine composition and its preparation method and application for improving skin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049350C (en) * | 1996-11-15 | 2000-02-16 | 曲贵民 | Medicine for psoriasis |
| CN1217200A (en) * | 1997-11-14 | 1999-05-26 | 黄国泉 | Oral medicine for treating psoriasis and preparation method therefor |
-
2005
- 2005-04-25 CN CNB2005100432720A patent/CN1332702C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101628057B (en) * | 2009-08-14 | 2011-04-13 | 南宁市维威制药有限公司 | Pharmaceutical composition for treating senile skin pruritus and preparation method thereof |
| CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
| CN106491772A (en) * | 2016-02-03 | 2017-03-15 | 中卫清华园生物科技有限公司 | One kind treats psoriasic external use health medicine |
| CN105770817A (en) * | 2016-04-08 | 2016-07-20 | 陈正琴 | Qi-tonifying, blood-activating, dehumidifying and detoxifying different-skin-disease-treating traditional-Chinese-medicine composition formula |
| CN106038859A (en) * | 2016-06-29 | 2016-10-26 | 合江商业街阳春中医诊所 | Traditional Chinese medicine composition and preparation method thereof |
| CN110123983A (en) * | 2018-02-02 | 2019-08-16 | 郑思维 | Chinese medicine composition and its preparation method and application for improving skin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1332702C (en) | 2007-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1062144C (en) | Yisuishengxue chinese medicine preparation for tonifying marrow and promoting generation of blood | |
| CN101284121B (en) | Combination medicine for curing the hoary hair | |
| CN101028481A (en) | Medicinal liquor for treating hyperosteogency and koilorrhachic | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN101134085A (en) | Traditional Chinese medicine for treating apoplexy and hemiplegia | |
| CN1091609C (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
| CN100406050C (en) | A Chinese traditional medicinal preparation for improving sub-health disease | |
| CN1706488A (en) | Recipe of Chinese medicine for treating psoriasis | |
| CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN1247086A (en) | Process for making medical wine for treating rheumatism | |
| CN101757160A (en) | Itching-relieving soup | |
| CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN1128667A (en) | Thrombus-eliminating pills | |
| CN1698863A (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN103071079A (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1277577C (en) | Chinese traditional medicine for treating cerebral thrombosis, preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070822 Termination date: 20100425 |